Evidence map›Paper›PMID 24192979›Full record

Trial reportEuropean radiology2014

Diffusion-weighted MRI, 11C-choline PET and 18F-fluorodeoxyglucose PET for predicting the Gleason score in prostate carcinoma.

Joe H Chang, Daryl Lim Joon, Sze Ting Lee, Chee-Yan Hiew, Stephen Esler, Sylvia J Gong, Morikatsu Wada, David Clouston, Richard O'Sullivan, Yin P Goh and 6 more

Open access · greenAbstract readClinical TrialValidation Study
PubMed Publisher
In one paragraph

Trial report in European radiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical significance of prostateWorld journal of radiology · 2017
    Article
  4. Article
  5. Article
  6. PET/MRI in Oncological Imaging: State of the Art.Diagnostics (Basel, Switzerland) · 2015
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Joe H ChangRadiation Oncology Centre, Austin Health, 300 Waterdale Road, Heidelberg, VIC, 3084, Australia, joe.chang@austin.org.au.
Daryl Lim Joon
Sze Ting Lee
Chee-Yan Hiew
Stephen Esler
Sylvia J Gong
Morikatsu Wada
David Clouston
Richard O'Sullivan
Yin P Goh
Henri Tochon-Danguy
J Gordon Chan
Damien Bolton
Andrew M Scott
Vincent Khoo
Ian D Davis
Austin Health · AUUniversity of Melbourne · AUEastern Health · AUEpworth Hospital · AUMonash Health · AURoyal Marsden NHS Foundation Trust · GBTissuPath · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo evaluate the accuracy of transrectal ultrasound-guided (TRUS) biopsy, diffusion-weighted (DW) magnetic resonance imaging (MRI), (11)C-choline (CHOL) positron emission tomography (PET), and (18)F-fluorodeoxyglucose (FDG) PET in predicting the prostatectomy Gleason risk (GR).

methodsThe study included 21 patients who underwent TRUS biopsy and multi-technique imaging before radical prostatectomy. Values from five different tests (TRUS biopsy, DW MRI, CHOL PET, FDG PET, and combined DW MRI/CHOL PET) were correlated with the prostatectomy GR using Spearman's ρ. Tests that were found to have significant correlations were used to classify patients into GR groups.

resultsThe following tests had significant correlations with prostatectomy GR: TRUS biopsy (ρ = 0.617, P = 0.003), DW MRI (ρ = -0.601, P = 0.004), and combined DW MRI/CHOL PET (ρ = -0.623, P = 0.003). CHOL PET alone and FDG PET only had weak correlations. The correct GR classification rates were 67% with TRUS biopsy, 67% with DW MRI, and 76% with combined DW MRI/CHOL PET.

conclusionsDW MRI and combined DW MRI/CHOL PET have significant correlations and high rates of correct classification of the prostatectomy GR, the strength and accuracy of which are comparable with TRUS biopsy. KEY POINTS: • Accurate determination of the Gleason score is essential for prostate cancer management. • DW MRI ± CHOL PET correlated significantly with prostatectomy Gleason score. • These correlations are similar to that between TRUS biopsy and prostatectomy.

Indexed as

Diffusion Magnetic Resonance ImagingPositron-Emission TomographyAdenocarcinomaAgedBiopsyCarbon RadioisotopesCholineFluorodeoxyglucose F18HumansMaleMiddle AgedNeoplasm GradingPredictive Value of TestsProspective StudiesProstatectomyProstatic NeoplasmsCarbon RadioisotopesCholineFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID24192979
OpenAlexW2043891521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.